In vitro study of magnetite-amyloid β complex formation

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 6, 2012, Pages 974-980

  Mir, Mònica ^a,b   Tahirbegi, Islam Bogachan ^a,c   Valle Delgado, Juan José ^a,c,d   Fernàndez Busquets, Xavier ^a,c,d   Samitier, Josep ^a,b,c  

^a INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alzheimer pathology; Amyloid peptide (AB 42); Magnetite; Neurodegenerative disease

Indexed keywords

ABNORMAL CONCENTRATIONS; ALZHEIMER; ALZHEIMER'S DISEASE; AMYLOID DEPOSITION; AMYLOID PEPTIDES; BIOGENIC MAGNETITE; COMPLEX FORMATIONS; HUMAN BRAIN; IN-VITRO; INCURABLE DISEASE; MAGNETIC NANOPARTICLES; NEURODEGENERATIVE; SCANNING ELECTRON MICROSCOPE; SUPERCONDUCTING QUANTUM INTERFERENCE;

BRAIN; GLYCOPROTEINS; MAGNETIC FORCE MICROSCOPY; MAGNETITE NANOPARTICLES; NANOPARTICLES; NEURODEGENERATIVE DISEASES; PATHOLOGY; PEPTIDES; SCANNING ELECTRON MICROSCOPY;

MAGNETITE;

AMYLOID BETA PROTEIN; MAGNETIC NANOPARTICLE; MAGNETITE;

ALZHEIMER DISEASE; ARTICLE; COMPLEX FORMATION; FIBER; HUMAN; IN VITRO STUDY; QUANTUM MECHANICS; SCANNING ELECTRON MICROSCOPE; SCANNING FORCE MICROSCOPY; SURFACE PLASMON RESONANCE; SYNTHESIS;

AMYLOID BETA-PEPTIDES; BINDING SITES; MAGNETITE NANOPARTICLES; MATERIALS TESTING; PARTICLE SIZE; PROTEIN BINDING; SURFACE PROPERTIES;

EID: 84864110351     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.11.010     Document Type: Article

References (31)

1. Goodman L. Alzheimer's disease: a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J Nerv Ment Dis 1953, 118:97-130.
2. Ke Y., Qian Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2003, 2:246-253.
3. Zecca L., Youdim M.B.H., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004, 5:863-873.
4. Smith M.A., Harris P.L.R., Sayre L.M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 1997, 94:9866-9868.
5. 42. Free Radic Biol Med 2006, 40:557-569.
6. Kirschvink J.L., Kobayashi-Kirschvink A., Woodford B.J. Magnetite biomineralization in the human brain. Proc Natl Acad Sci U S A 1992, 89:7683-7687.
7. Hautot D., Pankhurst Q.A., Khan N., Dobson J. Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue. Proc R Soc Lond B (Suppl) 2003, 270:S62-S64.
8. Pankhurst Q., Hautot D., Khan N., Dobson J. Increased levels of magnetic iron compounds in Alzheimer's disease. J Alzheimers Dis 2008, 13:49-52.
9. Collingwood J.F., Chong R.K.K., Kasama T., Cervera-Gontard L., Dunin-Borkowski R.E., Perry G., et al. Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis 2008, 14:235-245.
10. Cowley J.M., Janney D.E., Gerkin R.C., Buseck P.R. The structure of ferritin cores determined by electron nanodiffraction. J Struct Biol 2000, 131:210-216.
11. Quintana C., Cowley J.M., Marhic C. Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin. J Struct Biol 2004, 147:166-178.
12. Gálvez N., Fernández B., Sánchez P., Cuesta R., Ceolín M., Clemente-León M., et al. Comparative structural and chemical studies of ferritin cores with gradual removal of their iron contents. J Am Chem Soc 2008, 130:8062-8068.
13. Fisher P., Götz M.E., Danielczyk W., Gsell W., Riederer P. Blood transferrin and ferritin in Alzheimer's disease. Life Sci 1997, 60:2273-2278.
14. Zhang W., Shen H., Xie M.Q., Zhuang L., Deng Y.Y., Hu S.L., et al. Synthesis of carboxymethyl-chitosan-bound magnetic nanoparticles by the spraying co-precipitation method. Scr Mater 2008, 59:211-214.
15. 4) nanoparticles and its properties. J Magn Magn Mater 2010, 322:400-404.
16. Sato N., Okochi M., Taniyama Y., Kurinami H., Shimamura M., Takeuchi D., et al. Development of new screening system for Alzheimer disease, in vitro Aβ sink assay, to identify the dissociation of soluble Aβ from fibrils. Neurobiol Dis 2006, 22:487-495.
17. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J Biol Chem 2002, 277:32046-32053.
18. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 1989, 182:319-326.
19. Gaasch J.A., Geldenhuys W.J., Lockman P.R., Allen D.D., Van der Schyf C.J. Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem Res 2007, 32:1686-1693.
20. 1-42 reduces iron-induced toxicity in rat cerebral cortex. J Neurosci Res 2003, 73:316-323.
21. Kuo Y.M., Emmerling M.R., Vigo-Pelfrey C., Kasunici T.C., Kirkpatrick J.B., Murdoch G.H., et al. Water-soluble Aβ (N-40, N-42) oligomers in normal and alzheimer disease brains. J Biol Chem 1996, 271:4077-4081.
22. Atwood C.S., Perry G., Zeng H., Kato Y., Jones W.D., Ling K.Q., et al. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-β. Biochemistry 2004, 43:560-568.
23. Chikazumi S., Graham C.D. Physics of ferromagnetism 1997, 11. Oxford University Press, New York.
24. Lacheisserie E.T., Gignoux D., Schlenker M. Magnetism: fundamentals 2005, 80. Springer, New York.
25. 1-42 fibrillogenesis with atomic force microscopy. FASEB J 2005, 19:1344-1346.
26. Garzon-Rodriguez W., Yatsimirsky A.K., Glabe C.G. Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's Aβ peptide studied by fluorescence. Bioorg Med Chem Lett 1999, 9:2243-2248.
27. Nakamura M., Shishido N., Nunomura A., Smith M.A., Perry G., Hayashi Y., et al. Three histidine residues of amyloid-β peptide control the redox activity of copper and iron. Biochemistry 2007, 46:12737-12743.
28. Dobson J. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 2001, 496:1-5.
29. Regazzoni A.E., Urrutia G.A., Blesa M.A., Maroto A.J.G. Some observations on the composition and morphology of synthetic magnetites obtained by different routes. J Inorg Nucl Chem 1981, 43:1489-1493.
30. Harper J.D., Lieber C.M., Lansbury P.T. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein. Chem Biol 1997, 4:951-959.
31. Treiber C. Metals on the brain. Sci Aging Knowledge Environ 2005, 36:e27.